Persistent Asset Partners Ltd
Position in PHAT — Phathom Pharmaceuticals, Inc.
CIK 2056052
HONG KONG, K3
Position in PHAT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$297,369
+$83,093 QoQ
Shares Held
26,766
+107.2% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Persistent Asset Partners Ltd holds $59,094,384 across 109 Biotechnology names. PHAT ranks #49 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
133,066 | $4,329,967 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
92,516 | $3,560,940 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
15,905 | $3,006,840 | |
| 4 | ABVX |
Abivax S.A.
|
22,838 | $2,543,011 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
26,043 | $2,532,681 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
45,953 | $2,422,642 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
37,472 | $2,116,793 | |
| 8 | KOD |
Kodiak Sciences Inc.
|
51,336 | $1,956,928 |
All Filings in PHAT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $297,369 | 26,766 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $214,276 | 12,916 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $90,347 | 9,421 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||